The estimated Net Worth of John D Forsyth is at least $1.42 millió dollars as of 1 April 2022. Mr. Forsyth owns over 1,005 units of Baxter International stock worth over $1,100,895 and over the last 21 years he sold BAX stock worth over $0. In addition, he makes $320,944 as Independent Director at Baxter International.
John has made over 19 trades of the Baxter International stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 1,005 units of BAX stock worth $29,668 on 1 April 2022.
The largest trade he's ever made was exercising 11,610 units of Baxter International stock on 28 July 2011 worth over $358,865. On average, John trades about 1,344 units every 100 days since 2003. As of 1 April 2022 he still owns at least 28,034 units of Baxter International stock.
You can see the complete history of Mr. Forsyth stock trades at the bottom of the page.
John D. Forsyth is an Independent Director of the Company. Mr. Forsyth has been Chairman of Wellmark Blue Cross Blue Shield, a healthcare insurance provider for residents of Iowa and South Dakota, since 2000 and Chief Executive Officer since 1996. Prior to that, he spent 26 years at the University of Michigan, holding various positions, including President and Chief Executive Officer of the University of Michigan Health System. Mr. Forsyth currently serves as a director of the National Institute of Healthcare Management and previously served as a director of Baxalta, before it was acquired by Shire plc (Shire) in June 2016 and before Shire was acquired by Takeda Pharmaceutical Company in 2019.
As the Independent Director of Baxter International, the total compensation of John Forsyth at Baxter International is $320,944. There are 18 executives at Baxter International getting paid more, with Jose Almeida having the highest compensation of $13,913,800.
John Forsyth is 72, he's been the Independent Director of Baxter International since 2003. There are 2 older and 26 younger executives at Baxter International. The oldest executive at Baxter International Inc. is James Gavin, 74, who is the Independent Director.
John's mailing address filed with the SEC is ONE BAXTER PARKWAY, , DEERFIELD, IL, 60015.
Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney és Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Baxter International executives and other stock owners filed with the SEC include: